• The Daily Trade
  • Posts
  • Stryker's $4.9B Acquisition & California's Budget Boost: Key Market Insights You Can't Miss! 📈

Stryker's $4.9B Acquisition & California's Budget Boost: Key Market Insights You Can't Miss! 📈

The Daily Trade delivers sharp, daily insights on the US stock market.

Stay informed, spot trends, and trade with confidence.

Seeking impartial news? Meet 1440.

Every day, 3.5 million readers turn to 1440 for their factual news. We sift through 100+ sources to bring you a complete summary of politics, global events, business, and culture, all in a brief 5-minute email. Enjoy an impartial news experience.

Recent Headlines

Stryker's Bold Move: $4.9 Billion Acquisition of Inari Medical (9 minute read)
Stryker has announced its acquisition of Inari Medical for $80 per share, valued at approximately $4.9 billion. This strategic move will enhance Stryker's offerings in the peripheral vascular market, particularly in treating venous thromboembolism, a condition affecting up to 900,000 people annually in the U.S.


California's $229 Billion Budget: Thanks to a Stock Market Boom (1 minute read)
Governor Gavin Newsom has unveiled a $229 billion budget for the upcoming fiscal year, an increase from last year's $212 billion. The proposal anticipates $17 billion in extra revenue, largely attributed to a strong stock market performance, which heavily influences California's tax revenues.


Rocket Lab's Stock Soars: Is It a Buy Now? (5 minute read)
Rocket Lab USA's stock jumped 3.8% today, reaching $29.82. Analysts are weighing in, with some upgrading their ratings and price targets, suggesting a potential buying opportunity for investors as the space company continues to gain traction.


Reed's Inc. Secures $10 Million in Financing for Growth (4 minute read)
Reed's Inc. has successfully closed a $10 million private placement, selling shares at a premium price. The funds will be used to bolster growth strategies, including personnel investments and international expansion, as the company aims for sustainable profitability in 2025.


Kaiser Aluminum Welcomes New Leadership Amid Transition (5 minute read)
Kaiser Aluminum has appointed Keith A. Harvey as the new Chairman of the Board following the retirement of Jack A. Hockema. The board also welcomed Kimberly Glas as a new director, bringing valuable experience in manufacturing policy and advocacy.


Bionano Genomics Raises $10 Million to Strengthen Financial Position (6 minute read)
Bionano Genomics has completed a $10 million registered direct offering, aiming to use the funds for general corporate purposes and research. The offering involved a large number of shares at a low price, reflecting the company's strategic financial planning.


Fed's Cook Advocates Caution on Future Rate Cuts (2 minute read)
Federal Reserve Governor Lisa Cook has indicated that the central bank can afford to be cautious with further interest rate cuts, given the resilience of the labor market and persistent inflation challenges. The Fed's recent rate cuts have already eased monetary policy significantly.




Technical Analysis Results



Undervalued
PEP
PepsiCo, Inc.
Volume: 8.9M shares | Price: $146.27

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Buy
STOCH
Hold

Recent Mentions of PEP

The Smartest Dividend Stocks to Buy With $500 Right Now
Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some great deals.

5 Top Stocks to Buy in January
Naturally, investors are likely wondering how much longer the bull market rally can go.Here's why these five Fool.com contributors have high conviction in Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL), Micron Technology (NASDAQ: MU), Brookfield Renewable (NYSE: BEP)(NYSE: BEPC), PepsiCo (NASDAQ: PEP), and United Parcel Service (NYSE: UPS) as top stocks to buy this month.




Undervalued
BF.B
Brown-Forman Corporation Class B
Volume: 5.0M shares | Price: $36.84

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of BF.B




Undervalued
SCI
Service Corporation International
Volume: 797.2K shares | Price: $77.36

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of SCI

Service Corporation International's (NYSE:SCI) five-year earnings growth trails the 17% YoY shareholder returns
Passive investing in index funds can generate returns that roughly match the overall market. But the truth is, you can...

SERVICE CORPORATION INTERNATIONAL DECLARES QUARTERLY CASH DIVIDEND
Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today announced that its Board of Directors has approved a quarterly cash dividend of thirty cents per share of common stock. The quarterly cash dividend announced today is payable on December 31, 2024 to shareholders of record at the close of business on December 13, 2024. While the Company intends to pay regular quarterly cash dividends for the foreseeable future, all subseq




Undervalued
UL
Unilever plc
Volume: 2.0M shares | Price: $55.43

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Hold
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Buy
STOCH
Hold

Recent Mentions of UL

Why Is Unilever PLC (NYSE:UL) Among the Best FTSE Dividend Stocks to Buy Now?
We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at where Unilever PLC (NYSE:UL) stands against the other FTSE dividend stocks. Goldman Sachs Research predicts moderate growth for the UK economy in 2025, with GDP rising 1.2%. That is slightly […]

Trending tickers: Nvidia, Foxconn, Rivian, Rolls-Royce and Unilever
The latest investor updates on stocks that are trending on Monday.




Undervalued
KDP
Keurig Dr Pepper Inc.
Volume: 7.4M shares | Price: $31.08

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Hold

Recent Mentions of KDP

Here’s Why RS Concentrated All Cap Value Strategy is Holding Keurig Dr Pepper (KDP)
RS Investments, an investment management company, released its “RS Concentrated All Cap Value Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here. During the third quarter, the rally of the year persisted, with the broad market, indicated by the S&P 500® Index, posting nearly a 6% return. This brings […]

Why Keurig Dr Pepper (KDP) Is the Best Brewery Stock to Buy According to Hedge Funds?
We recently published a list of 12 Best Brewery Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Keurig Dr Pepper Inc. (NASDAQ:KDP) stands against other best brewery stocks to buy according to hedge funds. The global alcohol industry is currently grappling with strict regulations, […]




Undervalued
RPM
RPM International, Inc.
Volume: 1.4M shares | Price: $120.43

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Hold
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Hold
ULTOSC
Buy
STOCH
Buy

Recent Mentions of RPM

Is RPM International Inc. (NYSE:RPM) Trading At A 24% Discount?
Key Insights RPM International's estimated fair value is US$160 based on 2 Stage Free Cash Flow to Equity RPM...

Is RPM International (RPM) A Buy Heading into Q2 Earnings Announcement?
The government's effort to boost US infrastructure has generated demand for RPM's products.




We want to hear from YOU!

Technical indicator analysis feedback request

Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.

Simply reply to this email with your thoughts. Every comment helps us serve you better.

Thank you for being a valued reader.

How would you rate today's newsletter?

If there's anything I can do better, please let me know so I can make improvements!

Login or Subscribe to participate in polls.

Technical Indicator Information

Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30

Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20

Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80

Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75

Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal

Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20

Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100

Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band

Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price

Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0

Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30

Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI

Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25

Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.

Disclaimers

The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.

Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.

The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.